A clinical stage, multi-strategy

holding company focused on investing in and accelerating novel life sciences

and bio-technology companies through FDA approved clinical trials. Through their

diverse experience and extensive industry network, They are building Medicus

into a leading pharmaceutical holding company, committed to delivering better

treatment outcomes and alleviate pain and suffering.

Utilizing a thesis driven collaborative process, they identify,

acquire and advance relatively de-risked clinical stage assets through clinical

development and commercialization.